Lipid abnormalities in HIV-infected patients are not correlated with lopinavir plasma concentrations.
Torti
Carlo
C
Quiros-Roldan
Eugenia
E
Regazzi-Bonora
Mario
M
De Luca
Andrea
A
Lo Caputo
Sergio
S
Di Giambenedetto
Simona
S
Patroni
Andrea
A
Villani
Paola
P
Micheli
Valeria
V
Carosi
Giampiero
G
D000328:Adult; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000097:blood / Q000302:isolation & purification / Q000627:therapeutic use; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D005260:Female; D015658:HIV Infections / Q000097:blood*; D006801:Humans; D008055:Lipids / Q000097:blood*; D061466:Lopinavir; D008297:Male; D008659:Metabolic Diseases / Q000097:blood* / Q000209:etiology*; D011744:Pyrimidinones / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015203:Reproducibility of Results
D019380:Anti-HIV Agents; D008055:Lipids; D011744:Pyrimidinones; D061466:Lopinavir